RE:RE:RE:RE:CDLAs stated, anything formal drug related has absolutely zero to do with near to medium to success. Most of us know that the drug approval odyssey is literally years and years to get even remotely close to the finish line. And even then, how many Ph3 drugs fail even with decent efficacy data? Tons.
Being a cannabis pharma company is a great idea, but won't matter a lick during this time when it matters most; which is now.
It is positive that the insiders were carved off a whole lot of the recent financing if they chose....would be nice if they took a sizable bite which would then also explain why they priced the financing so low.....why not got for an easy double??
Lemoyne wrote: Canadian drug licence? They said in prospectus they do not expect de drive revenues from this licence for the foreseeable future.